Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Journal of Lipid Research
|
February 15, 2026
USP25 deficiency suppresses diet-induced obesity via ubiquitination-degradation of PARP1 and Elovl3 downregulation
Bowen Xie, Junbo Li, Guobin Huang, et al.
Hepatology Communications
|
March 15, 2022
Transmembrane channel activity in human hepatocytes and cholangiocytes derived from induced pluripotent stem cells
Rodrigo M Florentino, Qin Li, Michael C Coard, et al.
Seminars in Liver Disease
|
August 31, 2022
From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation
Takashi Motomura, Lanuza A P Faccioli, Ricardo Diaz-Aragon, et al.
Hepatology Communications
|
September 24, 2021
Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver-Enriched Transcription Factors and Functional Proteins in End-Stage Cirrhotic Human Hepatocytes
Edgar N Tafaleng, Amitava Mukherjee, Aaron Bell, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
Fatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
International Journal of Molecular Sciences
|
July 26, 2019
Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse
Kemper Nunes Dos Santos, Rodrigo M Florentino, Andressa França, et al.
Oncology Letters
|
December 30, 2021
Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma
Marcone Loiola Dos Santos, Andressa França, Antônio Carlos Melo Lima Filho, et al.
International Journal of Molecular Sciences
|
September 9, 2023
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants
Lanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, et al.
Iscience
|
November 21, 2022
Biofabrication of synthetic human liver tissue with advanced programmable functions
Rodrigo M Florentino, Kazutoyo Morita, Nils Haep, et al.
Frontiers in Cell and Developmental Biology
|
September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy
Mengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Journal of Lipid Research
|
February 15, 2026
USP25 deficiency suppresses diet-induced obesity via ubiquitination-degradation of PARP1 and Elovl3 downregulation
Bowen Xie, Junbo Li, Guobin Huang, et al.
Hepatology Communications
|
March 15, 2022
Transmembrane channel activity in human hepatocytes and cholangiocytes derived from induced pluripotent stem cells
Rodrigo M Florentino, Qin Li, Michael C Coard, et al.
Seminars in Liver Disease
|
August 31, 2022
From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation
Takashi Motomura, Lanuza A P Faccioli, Ricardo Diaz-Aragon, et al.
Hepatology Communications
|
September 24, 2021
Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver-Enriched Transcription Factors and Functional Proteins in End-Stage Cirrhotic Human Hepatocytes
Edgar N Tafaleng, Amitava Mukherjee, Aaron Bell, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
Fatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
International Journal of Molecular Sciences
|
July 26, 2019
Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse
Kemper Nunes Dos Santos, Rodrigo M Florentino, Andressa França, et al.
Oncology Letters
|
December 30, 2021
Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma
Marcone Loiola Dos Santos, Andressa França, Antônio Carlos Melo Lima Filho, et al.
International Journal of Molecular Sciences
|
September 9, 2023
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants
Lanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, et al.
Iscience
|
November 21, 2022
Biofabrication of synthetic human liver tissue with advanced programmable functions
Rodrigo M Florentino, Kazutoyo Morita, Nils Haep, et al.
Frontiers in Cell and Developmental Biology
|
September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy
Mengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Page
of 5